ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov.

85,013 comparisons

Most participants first33,758 with no events in either group come last3,221 to 3,240 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants With Blood Transfusion37 of 1,117

33 of 1,110

0.3 points

-1.1 to 1.8

2,227NCT03407625

Foley Bulb With Oral Misoprostol for Induction of Labor

Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants That Needed Mechanical Ventilation in Delivery Room (Yes/No)2 of 1,117

4 of 1,110

-0.2 points

-0.8 to 0.3

2,227NCT03407625

Foley Bulb With Oral Misoprostol for Induction of Labor

Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants With Excess Blood Loss215 of 1,117

223 of 1,110

-0.8 points

-4.1 to 2.5

2,227NCT03407625

Foley Bulb With Oral Misoprostol for Induction of Labor

Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants Used General Anesthesia for Delivery29 of 1,117

24 of 1,110

0.4 points

-0.9 to 1.7

2,227NCT03407625

Foley Bulb With Oral Misoprostol for Induction of Labor

Whole Breast Irradiation + Sequential Boost vs Hypofractionated Whole Breast Irradiation + Concurrent Boost: serious adverse events18 of 1,100

20 of 1,123

-0.1 points

-1.3 to 1.0

2,223NCT01349322

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

CDB-2914 vs Levonorgestrel: Number of Participants With Pregnancy20 of 1,104

30 of 1,117

-0.9 points

-2.2 to 0.4

2,221NCT00551616

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

CDB-2914 vs Levonorgestrel: serious adverse events3 of 1,104

4 of 1,117

-0.1 points

-0.7 to 0.5

2,221NCT00551616

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

Intervention Group vs Control Group: Number of Participants Reporting Alcohol/Marijuana Use122 of 988

204 of 1,233

-4.2 points

-7.1 to -1.2

2,221NCT02909673

School Based Program to Prevent Teen Dating Violence

NOMAC-E2 vs DRSP-EE: serious adverse events32 of 1,666

6 of 554

0.8 points

-0.5 to 1.8

2,220NCT00413062

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

Sulopenem Etzadroxil/Probenecid vs Amoxicillin/Clavulanate: Clinical Success Modified Intent-to-treat Population851 of 1,107

849 of 1,107

0.2 points

-3.3 to 3.7

2,214NCT05584657

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

Sulopenem Etzadroxil/Probenecid vs Amoxicillin/Clavulanate: serious adverse events0 of 1,107

5 of 1,107

-0.5 points

-1.1 to -0.0

2,214NCT05584657

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

PG Dosing Patients vs Historical Controls: serious adverse events22 of 487

162 of 1,726

-4.9 points

-7.0 to -2.3

2,213NCT00927862

Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin

TDF/FTC vs Placebo: Condomless Receptive Anal Intercourse in the Previous 12 Weeks With Any Partners Regardless of Status.332 of 1,091

348 of 1,114

-0.8 points

-4.7 to 3.0

2,205NCT00458393

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With Heart Failure Death8 of 1,108

7 of 1,096

0.1 points

-0.7 to 0.9

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With Mortality, Disabling Stroke, or CV Hospitalization (for Heart Failure or Acute Ischemic Events)170 of 1,108

189 of 1,096

-1.9 points

-5.0 to 1.2

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With Mortality or Cardiovascular (CV) Hospitalization573 of 1,108

637 of 1,096

-6.4 points

-10.5 to -2.3

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With an Arrhythmic Death or Cardiac Arrest10 of 1,108

13 of 1,096

-0.3 points

-1.2 to 0.6

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With All-cause Mortality58 of 1,108

67 of 1,096

-0.9 points

-2.8 to 1.1

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With Composite of Total Mortality, Disabling Stroke, Serious Bleeding, or Cardiac Arrest in Patients Warranting Therapy for AF.89 of 1,108

101 of 1,096

-1.2 points

-3.5 to 1.2

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Left Atrial Ablation vs Rate or Rhythm Control Therapy: Number of Participants With Cardiovascular Death22 of 1,108

23 of 1,096

-0.1 points

-1.3 to 1.1

2,204NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Code

Show the call in
curl "https://conductscience.org/api/comparisons/v1?page=162"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=162

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03407625-bca4a802",
        "title": "Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants With Blood Transfusion",
        "summary": "37 of 1117 against 33 of 1110; risk difference 0.3 points, 95% interval -1.1 to 1.8; NCT03407625, Foley Bulb With Oral Misoprostol for Induction of Labor",
        "record": "/library/comparisons/NCT03407625-bca4a802",
        "nct_id": "NCT03407625",
        "kind": "outcome",
        "participants": 2227,
        "risk_difference": {
          "value": 0.0033947107358029485,
          "lower": -0.011386856870000402,
          "upper": 0.018253110099718514
        },
        "group_1": "37 of 1,117",
        "group_2": "33 of 1,110",
        "difference": "0.3 points",
        "interval": "-1.1 to 1.8",
        "trial_title": "Foley Bulb With Oral Misoprostol for Induction of Labor"
      },
      {
        "id": "NCT03407625-ca9503d4",
        "title": "Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants That Needed Mechanical Ventilation in Delivery Room (Yes/No)",
        "summary": "2 of 1117 against 4 of 1110; risk difference -0.2 points, 95% interval -0.8 to 0.3; NCT03407625, Foley Bulb With Oral Misoprostol for Induction of Labor",
        "record": "/library/comparisons/NCT03407625-ca9503d4",
        "nct_id": "NCT03407625",
        "kind": "outcome",
        "participants": 2227,
        "risk_difference": {
          "value": -0.001813093308169405,
          "lower": -0.007586555095471037,
          "upper": 0.0033899212489292944
        },
        "group_1": "2 of 1,117",
        "group_2": "4 of 1,110",
        "difference": "-0.2 points",
        "interval": "-0.8 to 0.3",
        "trial_title": "Foley Bulb With Oral Misoprostol for Induction of Labor"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=163",
  "request_id": "og-ZJaAJ4Ep4qX89"
}

Ask about these results. The first 10 go in the prompt.

About this data
Holds
85,013 comparisons
From ClinicalTrials.gov. Counted 10 Nov 2026.
Release
23 Mar 2026
trial-comparisons-2026-03-23-0.1.0
Checked
20 of 20 review comparisons traced to ClinicalTrials.gov, and all 510,078 numbers calculated again apart from the builder agree
Access
Open
No account. 60 calls a minute from one address.

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

Opens sequences.conductscience.org

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?